Based on that the differentiated retinoblastoma cells are mostly photoreceptors [32], our result provides that anti-VEGF therapies would affect to the maintenance or function of photoreceptors in mature retina, which is supported by a recent report that the neutralization of endogenous VEGF leads to unexpected neural toxicity [29]. The gene discussed is VEGFA; the disease is retinoblastoma.